HighTower Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,324
Closed -$224K 3759
2023
Q2
$224K Buy
3,324
+24
+0.7% +$1.53K ﹤0.01% 2784
2023
Q1
$225K Sell
3,300
-1,665
-34% -$99.3K ﹤0.01% 2667
2022
Q4
$260K Buy
+4,965
New +$269K ﹤0.01% 2579
2021
Q2
Sell
-19,530
Closed -$1.91M 3401
2021
Q1
$1.91M Buy
+19,530
New +$1.78M 0.01% 1148
2017
Q2
Sell
-5,298
Closed -$306K 2336
2017
Q1
$306K Sell
5,298
-896
-14% -$53.5K ﹤0.01% 1543
2016
Q4
$375K Buy
6,194
+326
+6% +$21.2K ﹤0.01% 1371
2016
Q3
$410K Sell
5,868
-100
-2% -$6.6K ﹤0.01% 1324
2016
Q2
$331K Sell
5,968
-278
-4% -$16.8K ﹤0.01% 1286
2016
Q1
$376K Sell
6,246
-2,780
-31% -$164K ﹤0.01% 1504
2015
Q4
$573K Buy
9,026
+2,802
+45% +$182K 0.01% 1251
2015
Q3
$416K Sell
6,224
-98
-2% -$6.93K 0.01% 1291
2015
Q2
$432K Hold
6,322
0.01% 1071
2015
Q1
$351K Buy
6,322
+62
+1% +$3.18K 0.01% 1185
2014
Q4
$321K Buy
6,260
+300
+5% +$14.7K ﹤0.01% 1198
2014
Q3
$220K Sell
5,960
-500
-8% -$18K ﹤0.01% 1329
2014
Q2
$252K Buy
6,460
+754
+13% +$28K ﹤0.01% 1315
2014
Q1
$215K Buy
+5,706
New +$199K ﹤0.01% 1290

Other funds holding USNA

HighTower Advisors's USNA Position: Q3 2023 in Review

HighTower Advisors sold out of Usana Health Sciences (USNA) in Q3 2023, closing a stake of 3,324 shares — an estimated $224K sold.

HighTower Advisors first reported a position in USNA in Q1 2014 and held it in 17 quarters. The position peaked at $1.91M in Q1 2021. 160 funds tracked by Wall St. Rank hold USNA as of Q3 2023.

  • HighTower Advisors reported no remaining Usana Health Sciences position as of Q3 2023 after selling out during the quarter.
  • HighTower Advisors sold 3,324 Usana Health Sciences shares in Q3 2023, an estimated $224K.
  • HighTower Advisors first reported a position in Usana Health Sciences in Q1 2014 and held it in 17 quarters.
  • HighTower Advisors's Usana Health Sciences position peaked at $1.91M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2023.

Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.